Joel David Mayersohn serves as Executive at QSAM Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Joel David Mayersohn has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 19, 2025 involved receiving (via award) 300,000 shares valued at $0.
Joel David Mayersohn currently holds 321,228 shares of QSAM Biosciences, Inc. (QSAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joel David Mayersohn has been a net neutral trader of QSAM stock. They have purchased $0 and sold $0 worth of shares.
Joel David Mayersohn's most recent insider trade was on Sep 19, 2025, when they sold 300,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 19, 2025 | CTOR | $0 | Award | 300,000 | $N/A | Discretionary |
| Jul 28, 2025 | CTOR | $0 | Other | 21,228 | $N/A | Discretionary |
| Dec 15, 2021 | QSAM | $0 | Award | 400,000 | $N/A | Discretionary |
| Dec 17, 2020 | QSAM | $21.3K | Award | 96,782 | $0.22 | Discretionary |
| Sep 30, 2020 | QSAM | $73.0K | Conversion | 331,834 | $0.22 | Discretionary |